FDA Twitter Guidance Lacks Flexibility, And May Be Unconstitutional, Critics Say
This article was originally published in The Gray Sheet
Executive Summary
Stakeholders say the agency’s communication requirements for space-limited online platforms are too restricting and violate the First Amendment. Many of them are calling on the agency to withdraw the guidance and try again. The device industry has a comparatively toned down response so far, but wants more flexibility.